Provenance du réseau au premier degré de Nicole Barna
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 17 | |
| Private Company | Pharmaceuticals: Major | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nicole Barna via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member President Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Founder Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| BG MEDICINE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ARCH CAPITAL GROUP LTD. | Multi-Line Insurance | Director/Board Member Director/Board Member | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Graduate Degree | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Hemab ApS develops antibodies for the treatment of rare bleeding disorders. The company is based in Copenhagen, Denmark. The Danish company was founded in 2019 by Johan Henrik Faber. Benny Sorensen has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Chief Executive Officer | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer Chief Administrative Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| VBI VACCINES INC. | Biotechnology | Chairman Director/Board Member | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
Sahayata Microfinance Pvt Ltd.
 Sahayata Microfinance Pvt Ltd. Finance/Rental/LeasingFinance Sahayata Microfinance Pvt Ltd. engages in arranging loans. The company was founded in September 2006 and is headquartered in Udaipur, India. | Finance/Rental/Leasing | Chief Executive Officer | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer | |
| Jai Narain Vyas University | College/University | Masters Business Admin | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Rajasthan | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Pharmaceuticals: Major | Chairman | |
| Arizona State University | College/University | Undergraduate Degree | |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Samsung Bioepis Co., Ltd.
 Samsung Bioepis Co., Ltd. Pharmaceuticals: MajorHealth Technology Samsung Bioepis Co., Ltd. manufactures biopharmaceutical products. The company was founded on February 28, 2012 and is headquartered in Incheon, South Korea. | Pharmaceuticals: Major | Director/Board Member | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The California State University | College/University | Graduate Degree | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 41 |
| Inde | 4 |
| Bermudes | 2 |
| Danemark | 2 |
| Japon | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 177 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 64 |
| Chairman | 34 |
| Director of Finance/CFO | 32 |
Relations les plus connectées
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Theo Melas-Kyriazi | 26 |
| Briggs Morrison | 26 |
| Alexander Denner | 25 |
| Timothy Harris | 19 |
| Brian Posner | 19 |
| John Cox | 15 |
| Linda Bain | 15 |
| Geno Germano | 15 |
| Louis Paglia | 15 |
| Eric S. Lander | 15 |
| William Sibold | 14 |
| Richard Brudnick | 13 |
| Susan Altschuller | 12 |
| Anna Protopapas | 12 |
- Bourse
- Insiders
- Nicole Barna
- Connexions Sociétés
